Related Experiment Video
Updated: Jan 19, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Effectiveness Oral Theophylline, Piracetam, and Iron Treatments in Children With Simple Breath-Holding Spells
Alper I Dai1, Abdullah T Demiryürek2
1Faculty of Medicine, Department of Pediatric Neurology, University of Gaziantep, Gaziantep, Turkey.
Insights
Theophylline and iron treatments significantly reduced breath-holding spells (BHS) in children. Theophylline showed the highest effectiveness in decreasing spell frequency and improving caregiver satisfaction.
Area of Science:
- Pediatrics
- Neurology
Background:
- Breath-holding spells (BHS) are frequent nonepileptic events in children.
- Simple BHS management often lacks clear treatment guidelines.
Purpose of the Study:
- To compare the efficacy of oral theophylline, piracetam, and iron in managing simple BHS in pediatric patients.
Main Methods:
- Retrospective study of 146 children with simple BHS.
- Four groups: no treatment, theophylline, piracetam, and iron (for anemia).
- Evaluations included neurological, cardiological, and biochemical assessments.
Main Results:
- Theophylline (82.9%) and iron (58.8%) treatments markedly decreased BHS frequency.
- Piracetam and the non-treated groups showed minimal reduction (8.8% and 4.7%).
- Parental satisfaction was significantly higher with theophylline treatment (P < .001).
Conclusions:
- Theophylline is the most effective treatment for reducing the frequency of simple BHS in children.
- Iron therapy is beneficial for children with BHS and iron deficiency anemia.
- Piracetam showed no significant benefit in this study population.
Abstract:
Breath-holding spells (BHS) are common nonepileptic paroxysmal events in children. This is a retrospective study to compare the effectiveness of oral theophylline, piracetam, and iron treatments in children with simple BHS. A total of 146 children (75 girls and 71 boys) with simple BHS were included to this retrospective study. Children were divided into 4 groups: nontreated (no anemia and no treatment), oral theophylline (10 mg/kg/d as a single daily dose), piracetam (40 mg/kg/d in 2 divided doses), and elementary iron (3 mg/kg/d as a single daily dose) treatments. Iron therapy had been given only in children with iron deficiency anemia. Neurologic, cardiologic, and biochemical evaluations were performed for all children. The majority of the patients had cyanotic spells (83.6%). The frequency of attacks/month was markedly decreased with iron (58.8%) and theophylline (82.9%) treatments, but not with piracetam therapy (8.8%) and nontreated group (4.7%). Satisfaction of the parents/caregivers was found to be high in the theophylline group (P < .001). Our results showed that theophylline was the most effective therapy to decrease the frequency of simple BHS in children.
Related Concept Videos
10:42Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
06:09Breath Collection from Children for Disease Biomarker Discovery
11:38Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
07:01Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children
Breathing
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

